Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States

PaperCitations, authors & open-access status

Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 105 citations, 2016 year and hybrid oa status.

105
Citations
2016
Year
hybrid
OA Status

Related on ScholarIQ

Jack Mardekian
Author
International Journal of Clinical Practice
Journal
Atrial Fibrillation Management and Outcomes
Topic
Atrial Fibrillation Management and Outcomes
Topic
Vitamin K Research Studies
Topic
Intracerebral and Subarachnoid Hemorrhage Research
Topic
470M+ articles · free account